Anticoagulation with direct-acting anticoagulants decreases the risk of cardiovascular adverse events in patients with heart failure and atrial fibrillation compared to acenocoumarol

被引：0
|
作者：
Gonzalez Leal, A. [1 ]
Sanchez Vega, J. D. [1 ]
Antonana Ugalde, S. [1 ]
Arteagoitia Bolumburu, A. [1 ]
Alvarez-Garcia, J. [1 ]
Del Prado, S. [1 ]
Cordero, D. [1 ]
Jimenez-Blanco, M. [1 ]
Castillo, M. [1 ]
Gonzalez Ferrer, E. [1 ]
Zamorano, J. L. [1 ]
Alonso Salinas, G. L. [2 ]
机构：
[1] Hosp Ramon & Cajal, Cardiol Dept, Madrid, Spain
[2] Hosp Complex Navarra, Pamplona, Spain
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2021年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：287 / 287
页数：1
相关论文
共 50 条
  • [21] Direct-Acting Oral Anticoagulants Versus Warfarin in Medicare Patients With Chronic Kidney Disease and Atrial Fibrillation
    Wetmore, James B.
    Roetker, Nicholas S.
    Yan, Heng
    Reyes, Jorge L.
    Herzog, Charles A.
    STROKE, 2020, 51 (08) : 2364 - 2373
  • [22] Development and Validation of the DOAC Score: A Novel Bleeding Risk Prediction Tool for Patients With Atrial Fibrillation on Direct-Acting Oral Anticoagulants
    Aggarwal, Rahul
    Ruff, Christian T.
    Virdone, Saverio
    Perreault, Sylvie
    Kakkar, Ajay K.
    Palazzolo, Michael G.
    Dorais, Marc
    Kayani, Gloria
    Singer, Daniel E.
    Secemsky, Eric
    Piccini, Jonathan
    Tahir, Usman A.
    Shen, Changyu
    Yeh, Robert W.
    CIRCULATION, 2023, 148 (12) : 936 - 946
  • [23] Anticoagulation in patients with atrial fibrillation and congestive heart failure
    Veloso, HH
    de Paola, AAV
    AMERICAN JOURNAL OF CARDIOLOGY, 2005, 95 (12): : 1533 - 1533
  • [24] Efficacy and Safety of Direct-Acting Oral Anticoagulants Compared to Vitamin K Antagonists for Atrial Fibrillation in Patients with Liver Cirrhosis: A Meta-Analysis
    Miranda, Maria Clara Ramos
    Santos, Charles Karel
    Barbosa, Gabriel
    Nogueira, Thallys
    Menezes, Antonio da Silva, Jr.
    CIRCULATION, 2024, 150
  • [25] Local experience with the use of direct-acting oral anticoagulants in patients with atrial fibrillation and significant valvulopathy or biological prosthesis
    Lopez-Garrido, M. A.
    Becerra-Munoz, V. M.
    Orellana-Figueroa, H. N.
    Gomez-Doblas, J. J.
    REVISTA CLINICA ESPANOLA, 2016, 216 (04): : 234 - 236
  • [26] Heart Failure and Major Adverse Cardiovascular Events in Atrial Fibrillation Patients: A Retrospective Primary Care Cohort Study
    Molto-Balado, P.
    Reverte-Villarroya, S.
    Monclus-Arasa, C.
    Balado-Albiol, M. T.
    Baset-Martinez, S.
    Carot-Domenech, J.
    Clua-Espuny, J. L.
    BIOMEDICINES, 2023, 11 (07)
  • [27] The Burden of Major Bleeds among Atrial Fibrillation Patients Treated With Direct-acting Oral Anticoagulants in the United States
    Fermann, G. J.
    Lovelace, B.
    McNeil-Posey, K.
    Lingohr-Smith, M.
    Lin, J.
    Deitelzweig, S. B.
    ANNALS OF EMERGENCY MEDICINE, 2020, 76 (04) : S5 - S5
  • [28] Relative effectiveness of direct-acting oral anticoagulants by dose in patients with atrial fibrillation: A network meta-analysis
    Oh, Sang-Hyeon
    Cheon, Seonghyun
    Chung, Jee-Eun
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 251 - 252
  • [29] Association between direct-acting oral anticoagulants vs. warfarin with the risk of osteoporosis in patients with non-valvular atrial fibrillation
    Akhtar, Tauseef
    Hajra, Adrija
    Bhyan, Poonam
    Ghosh, Raktim K.
    Bandyopadhyay, Dhrubajyoti
    Aronow, Wilbert S.
    IJC HEART & VASCULATURE, 2020, 27
  • [30] Risk of cardiovascular events and incident atrial fibrillation in patients without prior atrial fibrillation: Implications for expanding the indications for anticoagulation
    Yao, Xiaoxi
    Gersh, Bernard J.
    Sangaralingham, Lindsey R.
    Shah, Nilay D.
    Noseworthy, Peter A.
    AMERICAN HEART JOURNAL, 2018, 199 : 137 - 143
12345